104 related articles for article (PubMed ID: 38942292)
1. Impact of Colloidal Drug-Rich Droplet Size and Amorphous Solubility on Drug Membrane Permeability: A Comprehensive Analysis.
Ueda K; Takemoto S; Higashi K; Moribe K
J Pharm Sci; 2024 Jun; ():. PubMed ID: 38942292
[TBL] [Abstract][Full Text] [Related]
2. Impact of Hypromellose Acetate Succinate Grade on Drug Amorphous Solubility and In Vitro Membrane Transport.
Ueda K; Hate SS; Taylor LS
J Pharm Sci; 2020 Aug; 109(8):2464-2473. PubMed ID: 32353454
[TBL] [Abstract][Full Text] [Related]
3. Polymer Type Impacts Amorphous Solubility and Drug-Rich Phase Colloidal Stability: A Mechanistic Study Using Nuclear Magnetic Resonance Spectroscopy.
Ueda K; Taylor LS
Mol Pharm; 2020 Apr; 17(4):1352-1362. PubMed ID: 32097023
[TBL] [Abstract][Full Text] [Related]
4. Partitioning of surfactant into drug-rich nanodroplets and its impact on drug thermodynamic activity and droplet size.
Ueda K; Taylor LS
J Control Release; 2021 Feb; 330():229-243. PubMed ID: 33340567
[TBL] [Abstract][Full Text] [Related]
5. Variable-Temperature NMR Analysis of the Thermodynamics of Polymer Partitioning between Aqueous and Drug-Rich Phases and Its Significance for Amorphous Formulations.
Ueda K; Higashi K; Moribe K; Taylor LS
Mol Pharm; 2022 Jan; 19(1):100-114. PubMed ID: 34702040
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Investigation of Intestinal Drug Absorption Enhancement by Drug-Rich Nanodroplets Generated via Liquid-Liquid Phase Separation.
Yoshikawa E; Ueda K; Hakata R; Higashi K; Moribe K
Mol Pharm; 2024 Apr; 21(4):1745-1755. PubMed ID: 38501717
[TBL] [Abstract][Full Text] [Related]
7. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Pharm Res; 2016 May; 33(5):1276-88. PubMed ID: 26892947
[TBL] [Abstract][Full Text] [Related]
9. Direct NMR Monitoring of Phase Separation Behavior of Highly Supersaturated Nifedipine Solution Stabilized with Hypromellose Derivatives.
Ueda K; Higashi K; Moribe K
Mol Pharm; 2017 Jul; 14(7):2314-2322. PubMed ID: 28558250
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic elucidation of formation of drug-rich amorphous nanodroplets by dissolution of the solid dispersion formulation.
Ueda K; Higashi K; Moribe K
Int J Pharm; 2019 Apr; 561():82-92. PubMed ID: 30822504
[TBL] [Abstract][Full Text] [Related]
11. The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane.
Dahan A; Beig A; Ioffe-Dahan V; Agbaria R; Miller JM
AAPS J; 2013 Apr; 15(2):347-53. PubMed ID: 23242514
[TBL] [Abstract][Full Text] [Related]
12. Exploiting the Phenomenon of Liquid-Liquid Phase Separation for Enhanced and Sustained Membrane Transport of a Poorly Water-Soluble Drug.
Indulkar AS; Gao Y; Raina SA; Zhang GG; Taylor LS
Mol Pharm; 2016 Jun; 13(6):2059-69. PubMed ID: 27138900
[TBL] [Abstract][Full Text] [Related]
13. Amorphous Drug Solubility and Maximum Free Drug Concentrations in Cyclodextrin Solutions: A Quantitative Study Using NMR Diffusometry.
Ueda K; Higashi K; Moribe K
Mol Pharm; 2021 Jul; 18(7):2764-2776. PubMed ID: 34180226
[TBL] [Abstract][Full Text] [Related]
14. pH-Dependent Liquid-Liquid Phase Separation of Highly Supersaturated Solutions of Weakly Basic Drugs.
Indulkar AS; Box KJ; Taylor R; Ruiz R; Taylor LS
Mol Pharm; 2015 Jul; 12(7):2365-77. PubMed ID: 25984769
[TBL] [Abstract][Full Text] [Related]
15. A Mechanistic Study of Drug Mass Transport from Supersaturated Solutions Across PAMPA Membranes.
Hate SS; Mosquera-Giraldo LI; Taylor LS
J Pharm Sci; 2022 Jan; 111(1):102-115. PubMed ID: 34237298
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mobility Suppression of Ibuprofen-Rich Amorphous Nanodroplets by HPMC Revealed by NMR Relaxometry and Its Significance with Respect to Crystallization Inhibition.
Ueda K; Yamamoto N; Higashi K; Moribe K
Mol Pharm; 2019 Dec; 16(12):4968-4977. PubMed ID: 31661287
[TBL] [Abstract][Full Text] [Related]
17. Laser diffraction as a powerful tool for amorphous solid dispersion screening and dissolution understanding.
Paisana MC; Lino PR; Nunes PD; Pinto JF; Henriques J; Paiva AM
Eur J Pharm Sci; 2021 Aug; 163():105853. PubMed ID: 33865976
[TBL] [Abstract][Full Text] [Related]
18. Effect of Polymer Species on Maximum Aqueous Phase Supersaturation Revealed by Quantitative Nuclear Magnetic Resonance Spectroscopy.
Ueda K; Moseson DE; Pathak V; Taylor LS
Mol Pharm; 2021 Mar; 18(3):1344-1355. PubMed ID: 33595322
[TBL] [Abstract][Full Text] [Related]
19. Unusual Correlation between the Apparent Amorphous Solubility of a Drug and Solubilizer Concentration Revealed by NMR Analysis.
Ueda K; Higashi K; Moribe K
Mol Pharm; 2022 Sep; 19(9):3336-3349. PubMed ID: 35924819
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms and Extent of Enhanced Passive Permeation by Colloidal Drug Particles.
Narula A; Sabra R; Li N
Mol Pharm; 2022 Sep; 19(9):3085-3099. PubMed ID: 35998304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
